Task: Answer the multiple-choice question.
Question: Which compound exhibits a -15.217% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCn1nccc1C(=O)Nc1cc(Cl)cc(Cl)c1
(b) NC(=O)NC(=O)C(OC(=O)CCNS(=O)(=O)c1ccccc1)c1ccccc1
Answer: b. NC(=O)NC(=O)C(OC(=O)CCNS(=O)(=O)c1ccccc1)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
NC(=O)NC(=O)C(OC(=O)CCNS(=O)(=O)c1ccccc1)c1ccccc1
NC(=O)NC(=O)C(OC(=O)CCNS(=O)(=O)c1ccccc1)c1ccccc1
[2-(carbamoylamino)-2-oxo-1-phenylethyl] 3-(benzenesulfonamido)propanoate